Celularity (CELU) holder reports 0% ownership in new Schedule 13G/A
Rhea-AI Filing Summary
Celularity Inc. received Amendment No. 1 to a Schedule 13G from Lincoln Alternative Strategies LLC regarding its Class A common stock. The filer now reports beneficial ownership of 0 shares, representing 0% of the class, and indicates ownership of five percent or less of the stock. The certification states the securities were not acquired and are not held to change or influence control of Celularity and are not part of any control-related transaction.
Positive
- None.
Negative
- None.
FAQ
What does Lincoln Alternative Strategies LLC report in its Celularity (CELU) Schedule 13G/A?
What type of Celularity (CELU) securities are covered in this Schedule 13G/A?
How much voting and dispositive power does Lincoln Alternative Strategies LLC report over Celularity (CELU) shares?
What ownership percentage of Celularity (CELU) does Lincoln Alternative Strategies LLC now report?
Does the Schedule 13G/A for Celularity (CELU) indicate an attempt to influence control of the company?
Who signed the Celularity (CELU) Schedule 13G/A on behalf of Lincoln Alternative Strategies LLC?